« Previous
Next »
International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 5
, Pages 1319-1325
, 1 April 2009
No Detectable Hypoxia in Malignant Salivary Gland Tumors: Preliminary Results
References
- . Hypoxia—A key regulatory factor in tumour growth. Nat Rev Cancer. 2002;2:38–47
- . Hypoxic gene expression and metastasis. Cancer Metastasis Rev. 2004;23:293–310
- Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature. 1996;379:88–91
- The hypoxic tumour microenvironment, patient selection and hypoxia-modifying treatments. Clin Oncol (R Coll Radiol). 2007;19:385–396
- . Tumor hypoxia and malignant progression. Methods Enzymol. 2004;381:335–354
- . Hypoxia in cancer: Significance and impact on clinical outcome. Cancer Metastasis Rev. 2007;26:225–239
- . Clinical studies of hypoxia modification in radiotherapy. Semin Radiat Oncol. 2004;14:233–240
- Monoclonal antibody PAL-E specific for endothelium. Lab Invest. 1985;52:71–76
- . Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts. Microvasc Res. 1995;50:141–153
- . Variations in radiosensitivity of various types of malignant salivary-gland tumour. Acta Otolaryngol Suppl. 1969;263:186–188
- Hypoxia enhances c-Met/HGF receptor expression and signaling by activating HIF-1alpha in human salivary gland cancer cells. Oral Oncol. 2006;42:593–598
- Clinical trials of neutron radiotherapy in the United States. Bull Cancer Radiother. 1996;83(Suppl.):78s–86s
- Radiobiological rationale and patient selection for high-LET radiation in cancer therapy. Radiother Oncol. 2004;73(Suppl. 2):S1–S14
- A comparison of oral and intravenous pimonidazole in canine tumors using intravenous CCI-103F as a control hypoxia marker. Int J Radiat Oncol Biol Phys. 2006;64:592–602
- Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res. 2002;62:7066–7074
- The immunohistochemical assessment of hypoxia, vascularity and proliferation in bladder carcinoma. Radiother Oncol. 2004;72:159–168
- Functional significance of erythropoietin receptor expression in breast cancer. Lab Invest. 2002;82:911–918
- . Quantitative analysis of varying profiles of hypoxia in relation to functional vessels in different human glioma xenograft lines. Radiat Res. 2002;157:626–632
- Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone). J Nucl Med. 2006;47:989–998
- Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst. 2001;93:1337–1343
- . Regulation of glucose transport by hypoxia. Am J Kidney Dis. 1999;34:189–202
- . Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu Rev Biochem. 1995;64:375–401
- Hypoxia-induced angiogenesis of cultured human salivary gland carcinoma cells enhances vascular endothelial growth factor production and basic fibroblast growth factor release. Oral Oncol. 2001;37:77–83
- Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas. Oral Oncol. 2008;44:335–344
- Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma. Clin Cancer Res. 2005;11:97–106
- Distribution of hypoxia and proliferation associated markers in spontaneous canine tumors. Acta Oncol. 1995;34:345–349
- Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 2000;60:7075–7083
- Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res. 2002;62:7350–7356
- . Immunohistochemical study of epidermal growth factor receptor in adenoid cystic carcinoma of salivary gland origin. Head Neck. 2002;24:632–636
- Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands. J Clin Oncol. 2007;25:3978–3984
- Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis. Clin Cancer Res. 2005;11:5856–5862
- Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer. Cancer Res. 2005;65:338–348
- Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol. 2001;3:802–808
- Tyrosine phosphorylation controls PCNA function through protein stability. Nat Cell Biol. 2006;8:1359–1368
- The radioprotector Bowman-Birk proteinase inhibitor stimulates DNA repair via epidermal growth factor receptor phosphorylation and nuclear transport. Radiother Oncol. 2008;86:375–382
Supported by Grant KUN 98-1814 from the Dutch Cancer Society.
Conflict of interest: none.
PII: S0360-3016(08)02976-3
doi: 10.1016/j.ijrobp.2008.06.1927
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 5
, Pages 1319-1325
, 1 April 2009
